A recent op-ed does not recognize the important work of the Maryland Prescription Drug Affordability Board, writes Vincent ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...

The latest edition of the Patented Medicine Prices Review Board (PMPRB) CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...

Key Points Chesapeake sold 9,875 Eli Lilly and Company shares; estimated trade value of approximately $7.68 million, based on the average price for Q2 2025 Transaction represented 6.9% of fund AUM.

Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news ...

Kristian Harloff gives his reaction to 'The Conjuring: Last Rites' after leaving the theater. He shares why it felt like a generic horror film. Vera Farmiga and Patrick Wilson star. FBI: Rigged poker ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

As the president and CEO of Ascendiun, the nonprofit parent company of Blue Shield of California — one of California’s largest health insurers — I believe that all health care decision-making should ...

An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...